Vassilis Vargemezis

Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention

Dimitrios Tziakas, Georgios Chalikias, Dimitrios Stakos et al. · International Journal of Cardiology · 2011 · 82 citations

Percutaneous Coronary Intervention, Heart Failure, Cardiovascular Disease +12

Efficacy of Intravenous Methoxy Polyethylene Glycol-Epoetin Beta Administered Every 2 Weeks Compared With Epoetin Administered 3 Times Weekly in Patients Treated by Hemodialysis or Peritoneal Dialysis: A Randomized Trial

Marian Klinger, Manual Arias, Vassilis Vargemezis et al. · American Journal of Kidney Diseases · 2007 · 74 citations

Hemodialysis, Urology, Peritoneal Dialysis +7

Impact of Long-Term Cinacalcet, Ibandronate or Teriparatide Therapy on Bone Mineral Density of Hemodialysis Patients: A Pilot Study

Efstathios Mitsopoulos, Dominiki Economidou, Stavros Zanos et al. · American Journal of Nephrology · 2012 · 47 citations

Validation of a New Risk Score to Predict Contrast-Induced Nephropathy After Percutaneous Coronary Intervention

Dimitrios Tziakas, Georgios Chalikias, Dimitrios Stakos et al. · The American Journal of Cardiology · 2014 · 47 citations

Heart Failure, New Risk Score, Coronary Artery Disease +16

Peritoneal Dialysis: Better than, Equal to, or Worse than Hemodialysis? Data Worth Knowing before Choosing a Dialysis Modality

Elias Thodis, Ploumis Passadakis, Vassilis Vargemezis et al. · Peritoneal Dialysis International · 2001 · 46 citations

Dialysis Modality, Dialysis, Dialysis Therapy +16